Prevalence of HCV Antibodies in Haemodialysis Patients in Al Sharkia Governorate (Sector B)
Ghada Nagieb Elsherif;
Abstract
HCV infection still remains a major health problem that can cause substantial liver related morbidity and mortality in patients with ESRD.
The global prevalence of hepatitis C virus (HCV) infection estimated to be around 1.6 - 3% worldwide, Egypt has the
The global prevalence of hepatitis C virus (HCV) infection estimated to be around 1.6 - 3% worldwide, Egypt has the
Other data
| Title | Prevalence of HCV Antibodies in Haemodialysis Patients in Al Sharkia Governorate (Sector B) | Authors | Ghada Nagieb Elsherif | Keywords | Prevalence of HCV Antibodies in Haemodialysis Patients in Al Sharkia Governorate (Sector B) | Issue Date | 2012 | Description | HCV infection still remains a major health problem that can cause substantial liver related morbidity and mortality in patients with ESRD. The global prevalence of hepatitis C virus (HCV) infection estimated to be around 1.6 - 3% worldwide, Egypt has the |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 116543p7802.pdf | 422 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.